Vivani Medical, Inc. 8-K

What Happened
On March 26, 2026 Vivani Medical, Inc. announced its fourth‑quarter and full‑year financial results and provided a business update in a press release, which the company attached to a Form 8‑K (Item 2.02). The press release is included as Exhibit 99.1 to the filing. (The filing text contains an inconsistent exhibit title—one place references 2024 results and another references 2025 results—so investors should read the attached release for the definitive numbers.)

Key Details

• Date filed: March 26, 2026 (Form 8‑K reporting the press release).
• Filing items: Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Exhibits).
• Exhibit: Press release attached as Exhibit 99.1 containing the detailed quarterly and full‑year results and business update.
• Technical exhibit: Cover page is provided in Inline XBRL (Exhibit 104).

Why It Matters
Earnings and full‑year results impact how investors assess Vivani Medical’s financial performance, prospects, and valuation. Because the 8‑K references the press release rather than reproducing financial line items in the body of the filing, retail investors should read Exhibit 99.1 for revenue, net income/loss, guidance, and any operational updates. Also note the filing’s inconsistent year label for the release—verify dates and figures directly in the attached press release before making investment decisions.